These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Dose dependence of CTL precursor frequency induced by a DNA vaccine and correlation with protective immunity against influenza virus challenge. Fu TM; Guan L; Friedman A; Schofield TL; Ulmer JB; Liu MA; Donnelly JJ J Immunol; 1999 Apr; 162(7):4163-70. PubMed ID: 10201942 [TBL] [Abstract][Full Text] [Related]
4. Development of Th1 and Th2 populations and the nature of immune responses to hepatitis B virus DNA vaccines can be modulated by codelivery of various cytokine genes. Chow YH; Chiang BL; Lee YL; Chi WK; Lin WC; Chen YT; Tao MH J Immunol; 1998 Feb; 160(3):1320-9. PubMed ID: 9570550 [TBL] [Abstract][Full Text] [Related]
5. Enhancement of cellular and humoral immune responses to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine-expressing plasmids. Geissler M; Gesien A; Tokushige K; Wands JR J Immunol; 1997 Feb; 158(3):1231-7. PubMed ID: 9013964 [TBL] [Abstract][Full Text] [Related]
6. Use of B7 costimulatory molecules as adjuvants in a prime-boost vaccination against Visna/Maedi ovine lentivirus. de Andrés X; Reina R; Ciriza J; Crespo H; Glaria I; Ramírez H; Grilló MJ; Pérez MM; Andrésdóttir V; Rosati S; Suzan-Monti M; Luján L; Blacklaws BA; Harkiss GD; de Andrés D; Amorena B Vaccine; 2009 Jul; 27(34):4591-600. PubMed ID: 19538997 [TBL] [Abstract][Full Text] [Related]
7. Cells expressing an H chain Ig gene carrying a viral T cell epitope are lysed by specific cytolytic T cells. Zaghouani H; Krystal M; Kuzu H; Moran T; Shah H; Kuzu Y; Schulman J; Bona C J Immunol; 1992 Jun; 148(11):3604-9. PubMed ID: 1375250 [TBL] [Abstract][Full Text] [Related]
8. Delivery of multiple CD8 cytotoxic T cell epitopes by DNA vaccination. Thomson SA; Sherritt MA; Medveczky J; Elliott SL; Moss DJ; Fernando GJ; Brown LE; Suhrbier A J Immunol; 1998 Feb; 160(4):1717-23. PubMed ID: 9469429 [TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of chronic ethanol consumption on cellular immune responses to hepatitis C virus core protein are reversed by genetic immunizations augmented with cytokine-expressing plasmids. Geissler M; Gesien A; Wands JR J Immunol; 1997 Nov; 159(10):5107-13. PubMed ID: 9366440 [TBL] [Abstract][Full Text] [Related]
10. Intranasal immunization of a DNA vaccine with IL-12- and granulocyte-macrophage colony-stimulating factor (GM-CSF)-expressing plasmids in liposomes induces strong mucosal and cell-mediated immune responses against HIV-1 antigens. Okada E; Sasaki S; Ishii N; Aoki I; Yasuda T; Nishioka K; Fukushima J; Miyazaki J; Wahren B; Okuda K J Immunol; 1997 Oct; 159(7):3638-47. PubMed ID: 9317164 [TBL] [Abstract][Full Text] [Related]
11. Plasmid DNA vaccines are effective in the absence of IFNgamma. Hassett DE; Zhang J; Whitton JL Virology; 1999 Oct; 263(1):175-83. PubMed ID: 10544092 [TBL] [Abstract][Full Text] [Related]
12. Priming MHC-I-restricted cytotoxic T lymphocyte responses to exogenous hepatitis B surface antigen is CD4+ T cell dependent. Wild J; Grusby MJ; Schirmbeck R; Reimann J J Immunol; 1999 Aug; 163(4):1880-7. PubMed ID: 10438922 [TBL] [Abstract][Full Text] [Related]
13. A plasmid encoding murine granulocyte-macrophage colony-stimulating factor increases protection conferred by a malaria DNA vaccine. Weiss WR; Ishii KJ; Hedstrom RC; Sedegah M; Ichino M; Barnhart K; Klinman DM; Hoffman SL J Immunol; 1998 Sep; 161(5):2325-32. PubMed ID: 9725227 [TBL] [Abstract][Full Text] [Related]
14. Engineering of in vivo immune responses to DNA immunization via codelivery of costimulatory molecule genes. Kim JJ; Bagarazzi ML; Trivedi N; Hu Y; Kazahaya K; Wilson DM; Ciccarelli R; Chattergoon MA; Dang K; Mahalingam S; Chalian AA; Agadjanyan MG; Boyer JD; Wang B; Weiner DB Nat Biotechnol; 1997 Jul; 15(7):641-6. PubMed ID: 9219266 [TBL] [Abstract][Full Text] [Related]
15. Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma. Abaitua F; Rodríguez JR; Garzón A; Rodríguez D; Esteban M Virus Res; 2006 Mar; 116(1-2):11-20. PubMed ID: 16214252 [TBL] [Abstract][Full Text] [Related]
16. Immunization with plasmid DNA encoding influenza A virus nucleoprotein fused to a tissue plasminogen activator signal sequence elicits strong immune responses and protection against H5N1 challenge in mice. Luo M; Tao P; Li J; Zhou S; Guo D; Pan Z J Virol Methods; 2008 Dec; 154(1-2):121-7. PubMed ID: 18789973 [TBL] [Abstract][Full Text] [Related]
17. DNA immunization with 2C FMDV non-structural protein reveals the presence of an immunodominant CD8+, CTL epitope for Balb/c mice. Barfoed AM; Rodriguez F; Therrien D; Borrego B; Sobrino F; Kamstrup S Antiviral Res; 2006 Dec; 72(3):178-89. PubMed ID: 16890298 [TBL] [Abstract][Full Text] [Related]
18. In vivo engineering of a cellular immune response by coadministration of IL-12 expression vector with a DNA immunogen. Kim JJ; Ayyavoo V; Bagarazzi ML; Chattergoon MA; Dang K; Wang B; Boyer JD; Weiner DB J Immunol; 1997 Jan; 158(2):816-26. PubMed ID: 8992999 [TBL] [Abstract][Full Text] [Related]
19. Costimulation provided by DNA immunization enhances antitumor immunity. Corr M; Tighe H; Lee D; Dudler J; Trieu M; Brinson DC; Carson DA J Immunol; 1997 Nov; 159(10):4999-5004. PubMed ID: 9366427 [TBL] [Abstract][Full Text] [Related]
20. CD86 (B7-2) can function to drive MHC-restricted antigen-specific CTL responses in vivo. Agadjanyan MG; Kim JJ; Trivedi N; Wilson DM; Monzavi-Karbassi B; Morrison LD; Nottingham LK; Dentchev T; Tsai A; Dang K; Chalian AA; Maldonado MA; Williams WV; Weiner DB J Immunol; 1999 Mar; 162(6):3417-27. PubMed ID: 10092797 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]